Eris to acquire branded formulations of Biocon subsidiary for Rs 1242 crore – Times of India
Biocon Biologics is selling its branded formulations business to Mumbai-based Eris Lifesciences for Rs 1242 crore.With the deal, Eris will jumpstart its entry into the Rs 30,000+ crore injectables market in India, and acquire two major insulin brands – Basalog and Insugen. This acquisition will also mark Eris’ entry into …